Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL2356867

CCCC[N+](CCCC)(CCCC)CCCC.F.F

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 4/20 0.92
▸ SLC22A2 O15244 1/20 0.79
▸ TSHR P16473 2/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ TP53 P04637 1/20 0.69
▸ CYP3A4 P08684 1/20 0.69
▸ ALOX15 P16050 1/20 0.69
▸ ALOX12 P18054 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ HIF1A Q16665 1/20 0.69
▸ HSD17B10 Q99714 1/20 0.69
▸ DNM1 Q05193 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL3232521 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL28519845 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL5717528 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL1847525 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL22658214 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL25325582 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL2794535 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL23647351 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL226111 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL3635739 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079227-A Green synthesis process and purification method of high-purity lithium hexafluoroarsenate — 2026-05-26 — — CN claimed
EP-4276063-B1 METHOD FOR PREPARING SULFURYL FLUORIDE BY ELECTROFLUORINATION CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) 2026-04-15 — — EP claimed
US-20260092239-A1 CLEANING COMPOSITION DONGWOO FINE CHEM CO LTD (KR) 2026-04-02 — — US claimed
WO-2025245089-A1 PROCESSES FOR PREPARING TETRALIN COMPOUNDS ARCUS BIOSCIENCES, INC. (US) 2025-11-27 — — WO claimed
US-20240102182-A1 METHOD FOR PREPARING SULFURYL FLUORIDE BY ELECTROFLUORINATION CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2024-03-28 — — US claimed
US-20230375937-A1 SUBSTRATE PROCESSING COMPOSITION AND SUBSTRATE PROCESSING METHOD USING THE SAME SK INC. (KR) 2023-11-23 — — US claimed
EP-4276063-A1 METHOD FOR PREPARING SULFURYL FLUORIDE BY ELECTROFLUORINATION Contemporary Amperex Technology Co., Limited (CN) 2023-11-15 — — EP claimed
WO-2023142047-A1 METHOD FOR PREPARING SULFURYL FLUORIDE BY ELECTROFLUORINATION 宁德时代新能源科技股份有限公司 2023-08-03 — — WO claimed
US-20220185810-A1 Novel Process for the Preparation of Filgotinib and Intermediates Thereof UNICHEM LABORATORIES LIMITED (IN) 2022-06-16 — — US claimed
EP-3947381-A2 NOVEL PROCESS FOR THE PREPARATION OF FILGOTINIB AND INTERMEDIATES THEREOF Unichem Laboratories Ltd (IN) 2022-02-09 — — EP claimed
WO-2020201975-A2 NOVEL PROCESS FOR THE PREPARATION OF FILGOTINIB AND INTERMEDIATES THEREOF UNICHEM LABORATORIES LIMITED (IN) 2020-10-08 — — WO claimed
WO-2019199073-A1 POLISHING COMPOSITION FOR GLASS SURFACE POLISHING, AND POLISHING APPARATUS AND POLISHING METHOD USING POLISHING COMPOSITION 삼성전자 주식회사 2019-10-17 — — WO claimed
US-10147969-B2 Electrolytic solution for electrochemical devices and electrochemical device in which the electrolytic solution is used PANASONIC CORPORATION (JP) 2018-12-04 — — US claimed
US-20170104237-A1 ELECTROLYTIC SOLUTION FOR ELECTROCHEMICAL DEVICES AND ELECTROCHEMICAL DEVICE IN WHICH THE ELECTROLYTIC SOLUTION IS USED KYOTO UNIVERSITY (JP) 2017-04-13 — — US claimed
US-20090104144-A1 Gypsum board with a fluorine-containing antifungal agent QUICK-MED TECHNOLOGIES, INC. (US) 2009-04-23 — — US claimed
US-6773822-B2 ANTIFUNGAL AGENT MAY BE PRESENT IN THE GYPSUM CORE AND/OR ON ONE OR BOTH OF THE PAPER FACINGS, AND MAY BE ENCAPSULATED IN A MATERIAL THAT RELEASES THE ANTIFUNGAL AGENT OVER TIME AND/OR UPON EXPOSURE TO MOISTURE. TEMPLE-INLAND FOREST PRODUCTS CORPORATION 2004-08-10 — — US claimed
US-4845258-A Production of gem-disubstituted cyclohexadienones ETHYL CORPORATION (US) 1989-07-04 — — US claimed
CN-122079227-A Green synthesis process and purification method of high-purity lithium hexafluoroarsenate — 2026-05-26 — — CN disclosed
EP-0165806-A2 Silylated vinyl alcohol polymers E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-12-27 — — EP disclosed
US-4544724-A REACTING ETHENOXYSILANE AND ALDEHYDE, POLYMERIZATION, THEN HYDROLYSIS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092239-A1 CLEANING COMPOSITION SETDB1, SETD7, ITGB2 SLC22A1 2900/4885SLC22A2 3032/4885TSHR 3616/4885
US-20220185810-A1 Novel Process for the Preparation of Filgotinib and Intermediates Thereof ABL1, JAK1, JAK3 SLC22A1 4630/4885SLC22A2 4640/4885TSHR 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback